Click here for printer-friendly version
- Net income was $1.29 per share, which included tax benefits of $0.04
per share and net realized investment gains of $0.01 per share
- Selling, general and administrative expense ratio continued to improve,
declining by 130 basis points from prior year and by 20 basis points
from second quarter of 2006
- Full year 2006 earnings guidance raised to $4.81 per share, including
tax benefits of $0.04 per share and net realized investment losses of
$0.01 per share
- Completed $4.0 billion in share repurchases year-to-date through
September 30, 2006, and repurchase authorization was increased to
$4.5 billion for 2006
INDIANAPOLIS, Oct. 25 /PRNewswire-FirstCall/ -- WellPoint, Inc.
(NYSE: WLP) today announced that third quarter 2006 net income was $810.8
million, or $1.29 per share, an increase of 26.5 percent from $1.02 per share
in the third quarter of 2005. Current quarter results included $0.04 per
share in tax benefits, resulting from a lower effective tax rate due to
changes in the Company's state tax apportionment factors following the
WellChoice acquisition, net realized investment gains of $0.01 per share and,
as expected, costs of $0.05 per share for expensing stock options in
accordance with FAS 123R.
"We are very pleased with our continued strong performance in 2006, and
our third quarter results reinforce our earnings growth expectations for the
remainder of the year," said Larry C. Glasscock, chairman, president and chief
executive officer of WellPoint, Inc. "Looking ahead to 2007, we anticipate
another year of robust growth in our National Accounts business, along with
further expansion of our Medicaid membership base following our recent
contract awards. As we enter the open enrollment season, we are seeing
significant interest and early activity for our Lumenos consumer-driven health
plans. These innovative and affordable CDHP products will be available
beginning January 1st for individuals, local group business and national
accounts. While we will release our specific 2007 outlook in December, we
expect continued earnings per share growth and further improvement in
operating margins through more efficient operations."
"We continue to focus on improving returns for our shareholders through
our share repurchase program," said David C. Colby, executive vice president
and chief financial officer of WellPoint, Inc. "During the third quarter, we
used $399.6 million to repurchase 5.4 million shares of our common stock and
the Board approved an additional $500 million in share repurchase
authorization, bringing our 2006 total authorization to $4.5 billion, which we
plan to utilize in the fourth quarter. Cash flow from operations was strong
for the quarter. While reported operating cash flow for the quarter was
$614.7 million, this amount included only two months of Centers for Medicare &
Medicaid Services ("CMS") payments which average $448.4 million per month. If
we had received three CMS payments during the quarter, operating cash flow
would have been 1.3 times net income for the third quarter. We continue to
expect strong cash flow during the next year and will continue to use our cash
to grow our business and maximize shareholder value."
COMPARABLE BASIS INFORMATION
On December 28, 2005, WellPoint, Inc. acquired WellChoice, Inc. For
accounting purposes, the transaction was assumed to have closed on
December 31, 2005. Accordingly, operations of the former WellChoice, Inc. are
included in reported financial results for 2006. However, operations of the
former WellChoice, Inc. are not included in reported financial results for
2005.
Unless otherwise indicated, the analysis in this press release compares
reported financial results and does not adjust results for the effects of this
acquisition. In certain areas, we have included "comparable basis" analyses
that we believe provide more meaningful comparisons between periods, due to
the inclusion of operations of the former WellChoice, Inc. in the comparable
historical results. The "comparable basis" information is not calculated in
accordance with U.S. generally accepted accounting principles ("GAAP") and is
not intended to represent or be indicative of the results that WellPoint, Inc.
would have reported had the acquisition been completed as of the dates
presented, and should not be taken as representative or indicative of our
future results. The methodologies for calculating the comparable basis
information are either described within the text of the press release, or in
the tables at the end of the press release where such comparable basis
information is reconciled to WellPoint, Inc.'s reported GAAP financial
results.
CONSOLIDATED HIGHLIGHTS
Membership: Medical enrollment totaled 34.2 million members at
September 30, 2006, an increase of 5.2 million members from 29.0 million at
September 30, 2005, including approximately 4.8 million members acquired
through the WellChoice transaction.
On a comparable basis, enrollment increased by 558,000 members since
September 30, 2005. Each of the Company's geographic regions experienced
growth, reflecting the strong diversity in the Company's medical membership
base.
From a customer segment perspective, the increase in membership was driven
by the National Accounts business, which grew by 765,000 members on a
comparable basis. Large, multi-state employers continue to be attracted to
WellPoint's superior value proposition, which includes broad, cost-effective
networks available through the BlueCard program, as well as cutting-edge
Lumenos consumer-driven capabilities and leading wellness and care management
programs. The Company also experienced growth of 134,000 members in its State
Sponsored operations during the past 12 months. With the ability to offer a
comprehensive array of health management services to the nation's Medicaid
recipients, the Company has been successful with several recent contract
awards in Indiana, Kansas, Ohio and Nevada.
Individual and Small Group ("ISG") and Senior businesses also experienced
growth over the past 12 months. Large Group enrollment declined from the
prior year, primarily due to the previously-announced losses of two large
groups totaling approximately 410,000 members.
Medicare Part D enrollment grew by 42,000 members during the quarter,
totaling 1.6 million members as of September 30, 2006. The Company is
well-positioned for continued success in this program based on the 2007 bid
information recently released by CMS.
Operating Revenue: Operating revenue was $14.2 billion in the third
quarter of 2006, an increase of 29.0 percent from $11.0 billion in the prior
year quarter.
On a comparable basis, third quarter 2006 operating revenue increased by
$1.6 billion, or 12.3 percent, versus $12.6 billion in the prior year period.
The increase resulted primarily from disciplined pricing, the addition of the
New York state prescription drug contract in 2006, enrollment in the Company's
Medicare Part D products and increased reimbursement in the Federal Employee
Program ("FEP").
Benefit Expense Ratio: The benefit expense ratio was 81.3 percent in the
third quarter of 2006, a 180 basis point increase compared with 79.5 percent
in the third quarter of 2005.
On a comparable basis, the benefit expense ratio increased by 80 basis
points, from 80.5 percent in the third quarter of 2005. The 80 basis point
increase primarily resulted from the addition of the New York state
prescription drug contract, which has a higher-than-average benefit expense
ratio, and increased medical expenses in the FEP, for which the Company is
reimbursed for its costs plus a fee.
The benefit expense ratio increased by 10 basis points sequentially, from
81.2 percent in the second quarter of 2006. Increased medical expenses in the
FEP resulted in a 20 basis point increase in the benefit expense ratio in the
third quarter, which was partially offset by other items including Medicare
Part D experience.
Premium and Cost Trends: Trends include Large Group and ISG fully-insured
businesses.
For the rolling 12-month period ended September 30, 2006, the primary
drivers of medical trend were inpatient and outpatient costs. Commercial
premium yield for the same period exceeded total cost trend, where total cost
trend included medical costs and selling, general and administrative ("SG&A")
expense, resulting in an increase in underwriting margin. The Company
continues to expect that full year 2006 medical cost trend will be less than
8.0 percent.
SG&A Expense Ratio: The SG&A expense ratio was 15.5 percent in the third
quarter of 2006, a decrease of 130 basis points from 16.8 percent in the third
quarter of 2005. The current quarter included costs for expensing stock
options in accordance with FAS 123R, which added 30 basis points to the SG&A
ratio.
On a comparable basis, the SG&A expense ratio declined by 110 basis
points, compared with 16.6 percent in the third quarter of 2005. The ratio
improved significantly year-over-year as the Company continued to control
spending, spread administrative expenses across a growing revenue base and
realize integration synergies and efficiencies.
The SG&A expense ratio declined by 20 basis points compared to 15.7
percent in the second quarter of 2006, reflecting continued leveraging of SG&A
costs across a growing revenue base. The Company remains confident in its
ability to further reduce the SG&A ratio, as even greater efficiencies are
achieved through the Company's new organizational structure.
Operating Cash Flow: For the first nine months of 2006, operating cash
flow totaled $2.6 billion, or 1.1 times net income. Operating cash flow
totaled $614.7 million in the third quarter, as the Company received only two
CMS monthly payments of approximately $448.4 million each. For the quarter,
operating cash flow was 0.8 times net income. If three monthly CMS payments
had been received during the quarter, operating cash flow would have been 1.3
times net income.
Days in Claims Payable: Days in claims payable as of September 30, 2006,
was 45.6 days, an increase of 0.8 days from 44.8 days as of June 30, 2006.
This increase was primarily due to an increase in claims payment cycle times
due to the migration away from certain legacy claims systems and the timing of
PBM pharmacy claim payments.
Share Repurchase Program: During the third quarter 2006, the Company
repurchased 5.4 million shares of its common stock for $399.6 million. The
Board of Directors increased the share repurchase authorization by $500
million on August 17, 2006, to $4.5 billion. As of September 30, 2006, there
was $500 million available under the Board's current repurchase authorization.
Based on the current stock price and strong year-to-date financial results,
the Company intends to utilize this remaining authorization during the fourth
quarter of 2006, subject to market conditions. At September 30, 2006, cash
and investments held at the parent company totaled approximately $1.5 billion.
REPORTABLE SEGMENTS
WellPoint, Inc. has three reportable segments: Health Care, Specialty and
Other. Operating revenue and operating gain are the key measures used by
management to evaluate performance in each segment.
WellPoint, Inc.
Reportable Segment Highlights
(Unaudited)
($ In Millions) Three Months Ended September 30
2006 2005 Change
Operating Revenue
Health Care $13,644.9 $10,493.4 30.0%
Specialty 902.7 768.8 17.4%
Other:
External Customers 114.8 84.8 35.4%
Intercompany Eliminations (463.9) (344.4) (34.7%)
Total Other (349.1) (259.6) (34.5%)
Total Operating Revenue 14,198.5 11,002.6 29.0%
Operating Gain (Loss)
Health Care $1,093.9 $905.6 20.8%
Specialty 128.7 100.2 28.4%
Other (15.0) (21.0) 28.6%
WellPoint, Inc.
Reportable Segment Highlights
(Unaudited)
($ In Millions) Nine Months Ended September 30
2006 2005 Change
Operating Revenue
Health Care $40,094.0 $31,251.4 28.3%
Specialty 2,637.3 2,272.3 16.1%
Other:
External Customers 346.1 257.2 34.6%
Intercompany Eliminations (1,321.9) (986.5) (34.0%)
Total Other (975.8) (729.3) (33.8%)
Total Operating Revenue 41,755.5 32,794.4 27.3%
Operating Gain (Loss)
Health Care $3,190.4 $2,539.5 25.6%
Specialty 380.4 293.6 29.6%
Other (55.6) (91.9) 39.5%
Health Care: Operating gain for the Health Care segment was approximately
$1.1 billion in the third quarter of 2006, an increase of 20.8 percent,
compared with $905.6 million in the third quarter of 2005.
On a comparable basis, third quarter 2006 operating gain increased by
$87.8 million, or 8.7 percent, compared with $1.0 billion in the prior year
quarter. Performance in the Health Care segment improved year-over-year due
to disciplined underwriting, enrollment in the Company's Medicare Part D
products and continued SG&A expense control. Operating gain in the third
quarter of 2006 included costs of $43.5 million for expensing stock options in
accordance with FAS 123R.
Specialty: Operating gain totaled $128.7 million in the third quarter of
2006, an increase of 28.4 percent compared with $100.2 million in the third
quarter of 2005 on both a reported and comparable basis. The increase
resulted primarily from higher PBM prescription volume with the addition of
Medicare Part D. The Company continues to see growth in its other ongoing
specialty operations.
OUTLOOK
Full Year 2006:
* The Company now expects net income of $4.81 per share, including tax
benefits of $0.04 per share and net realized investment losses of $0.01 per
share. This estimate assumes the Company completes its remaining share
repurchase authorization during the fourth quarter of 2006.
* Operating revenue is expected to total approximately $56.1 billion.
* The benefit expense ratio is expected to be approximately 81.0 percent.
* The SG&A expense ratio is expected to be approximately 15.9 percent.
* The Company now expects operating cash flow in excess of $3.8 billion,
including settlement of the multi-district litigation. In October 2006, the
court gave final approval to the Company's negotiated settlement and $209.5
million was paid to settle those claims.
* Year-end medical enrollment is expected to be approximately 34.3
million members.
Full Year 2007:
* The Company expects to achieve its targeted 15 percent growth in net
income per share in 2007. The Company is in the process of finalizing its
2007 annual plan and will provide formal guidance for 2007 at its Investor
Conference on December 12, 2006. A live webcast of this event will be
available at http://www.wellpoint.com .
Basis of Presentation
1. Operating gain is defined as operating revenue less benefit expense,
selling expense, general and administrative expense, and cost of drugs.
Operating gain is used to analyze profit or loss on a segment basis.
Consolidated operating gain is a non-GAAP measure.
2. On December 28, 2005, WellPoint, Inc. acquired WellChoice, Inc.
Accordingly, operations of the former WellChoice, Inc. are included in
reported financial results for 2006. However, operations of the former
WellChoice, Inc. are not included in reported financial results for 2005.
3. Amounts for 2005 and prior do not include the impact of expensing
stock options in accordance with FAS 123R. The Company's 2006 reported
results and its outlook for the remainder of 2006 and 2007, however, do
include this impact.
4. Certain prior period amounts have been reclassified to conform to
current period presentation.
Conference Call and Webcast
Management will host a conference call and webcast today at 8:30 a.m.
Eastern Daylight Time ("EDT") to discuss its third quarter earnings results
and updated outlook. The conference call should be accessed at least 15
minutes prior to the start of the call with the following numbers:
888-423-3268 (Domestic) 800-475-6701 (Domestic Replay)
651-291-5254 (International) 320-365-3844 (International Replay)
An access code is not required for today's conference call. The access
code for the replay is 842195. The replay will be available from 1:45 p.m.
EDT today until the end of the day on November 8, 2006. The call will also be
available through a live webcast at http://www.wellpoint.com under "Investor
Info." A webcast replay will be available following the call.
About WellPoint, Inc.
WellPoint's mission is to improve the lives of the people it serves and
the health of its communities. WellPoint, Inc. is the largest health benefits
company in terms of commercial membership in the United States. Through its
nationwide networks, the company delivers a number of leading health benefit
solutions through a broad portfolio of integrated health care plans and
related services, along with a wide range of specialty products such as life
and disability insurance benefits, pharmacy benefit management, dental,
vision, behavioral health benefit services, as well as long term care
insurance and flexible spending accounts. Headquartered in Indianapolis,
Indiana, WellPoint is an independent licensee of the Blue Cross and Blue
Shield Association and serves its members as the Blue Cross licensee for
California; the Blue Cross and Blue Shield licensee for Colorado, Connecticut,
Georgia, Indiana, Kentucky, Maine, Missouri (excluding 30 counties in the
Kansas City area), Nevada, New Hampshire, New York (as Blue Cross Blue Shield
in 10 New York City metropolitan and surrounding counties and as Blue Cross or
Blue Cross Blue Shield in selected upstate counties only), Ohio, Virginia
(excluding the Northern Virginia suburbs of Washington, D.C.), Wisconsin; and
through UniCare. Additional information about WellPoint is available at
http://www.wellpoint.com .
WellPoint, Inc.
Medical Membership & Specialty Metrics Summary
(Unaudited and in Thousands)
As Comparable
Reported Basis(1)
September September September December
30, 30, 30, 31,
Medical Membership 2006 2005 2005 2005
Customer Type
Large Group 15,926 13,268 16,292 16,362
Individual and Small
Group ("ISG") 5,651 5,294 5,636 5,645
National Accounts 5,144 3,505 4,745 4,776
BlueCard 4,214 4,023 3,848 3,915
Total National 9,358 7,528 8,593 8,691
Senior 1,231 1,073 1,221 1,224
State Sponsored 2,024 1,825 1,890 1,934
Total 34,190 28,988 33,632 33,856
Funding Arrangement
Self-Funded 16,937 14,650 16,400 16,584
Fully-Insured 17,253 14,338 17,232 17,272
Total 34,190 28,988 33,632 33,856
Regional Membership
East 13,776 8,740 13,629 13,800
Central 11,121 11,102 10,976 10,970
West 9,293 9,146 9,027 9,086
Total 34,190 28,988 33,632 33,856
Specialty Metrics
PBM Prescription
Volume(2) 90,308 84,711 84,711 91,813
Behavioral Health
Membership 16,048 13,804 13,804 15,669
Life and Disability
Membership 5,956 5,743 5,743 5,826
Dental Membership 5,193 5,107 5,372 5,195
Medicare Part D
Membership(3) 1,569 - - -
Vision Membership 1,255 785 785 816
Change from
Comparable
Basis(1)
September December
30, 31,
Medical Membership 2005 2005
Customer Type
Large Group (2.2%) (2.7%)
Individual and Small
Group ("ISG") 0.3% 0.1%
National Accounts 8.4% 7.7%
BlueCard 9.5% 7.6%
Total National 8.9% 7.7%
Senior 0.8% 0.6%
State Sponsored 7.1% 4.7%
Total 1.7% 1.0%
Funding Arrangement
Self-Funded 3.3% 2.1%
Fully-Insured 0.1% (0.1%)
Total 1.7% 1.0%
Regional Membership
East 1.1% (0.2%)
Central 1.3% 1.4%
West 2.9% 2.3%
Total 1.7% 1.0%
Specialty Metrics
PBM Prescription
Volume(2) 6.6% (1.6%)
Behavioral Health
Membership 16.3% 2.4%
Life and Disability
Membership 3.7% 2.2%
Dental Membership (3.3%) -
Medicare Part D
Membership(3) - -
Vision Membership 59.9% 53.8%
(1) "Comparable Basis" data was calculated by adding historical data for
the former WellChoice, Inc. to WellPoint, Inc.'s historical data, and
adjusting the combined totals to ensure a consistent approach for counting
membership and to eliminate overlapping BlueCard host membership.
(2) Represents quarterly prescription volume at the Company's PBM
operation.
(3) Includes auto-assigned, stand-alone, Medicare Advantage, group waive
and external PBM members with the prescription drug plan benefit.
WellPoint, Inc.
Consolidated Statements of Income
(Unaudited)
($ In Millions, Except Per Share Data) Three Months Ended
September 30
2006 2005 Change
Revenues
Premiums $13,180.3 $10,182.1 29.4%
Administrative fees 867.8 688.9 26.0%
Other revenue 150.4 131.6 14.3%
Total operating revenue 14,198.5 11,002.6 29.0%
Net investment income 222.8 154.7 44.0%
Net realized gains (losses) on
investments 4.6 (0.4) -
-
Total revenues 14,425.9 11,156.9 29.3%
Expenses
Benefit expense 10,720.8 8,096.2 32.4%
Selling, general and administrative
expense
Selling expense 415.7 370.6 12.2%
General and administrative expense 1,783.0 1,477.2 20.7%
Total selling, general and
administrative expense 2,198.7 1,847.8 19.0%
Cost of drugs 71.4 73.8 (3.3%)
Interest expense 105.6 56.1 88.2%
Amortization of other intangible assets 74.8 59.6 25.5%
Total expenses 13,171.3 10,133.5 30.0%
Income before income taxes 1,254.6 1,023.4 22.6%
Income taxes 443.8 382.7 16.0%
Net income $810.8 $640.7 26.5%
Net income per diluted share $1.29 $1.02 26.5%
Diluted shares (in millions) 630.6 627.7 0.5%
Benefit expense as a percentage of
premiums 81.3% 79.5% 180 bp
Selling, general and administrative
expense as a percentage of total
operating revenue 15.5% 16.8% (130)bp
Income before income taxes as a
percentage of total revenues 8.7% 9.2% (50)bp
WellPoint, Inc.
Consolidated Statements of Income
(Unaudited)
($ In Millions, Except Per Share Data) Nine Months Ended
September 30
2006 2005 Change
Revenues
Premiums $38,678.0 $30,394.8 27.3%
Administrative fees 2,628.9 2,013.8 30.5%
Other revenue 448.6 385.8 16.3%
Total operating revenue 41,755.5 32,794.4 27.3%
Net investment income 653.4 453.2 44.2%
Net realized (losses) gains on
investments (11.4) 1.4 -
-
Total revenues 42,397.5 33,249.0 27.5%
Expenses
Benefit expense 31,443.9 24,424.9 28.7%
Selling, general and administrative
expense
Selling expense 1,230.3 1,097.7 12.1%
General and administrative expense 5,333.1 4,312.1 23.7%
Total selling, general and
administrative expense 6,563.4 5,409.8 21.3%
Cost of drugs 233.0 218.5 6.6%
Interest expense 303.5 168.2 80.4%
Amortization of other intangible assets 223.1 178.7 24.8%
Total expenses 38,766.9 30,400.1 27.5%
Income before income taxes 3,630.6 2,848.9 27.4%
Income taxes 1,336.8 1,037.1 28.9%
Net income $2,293.8 $1,811.8 26.6%
Net income per diluted share $3.54 $2.90 22.1%
Diluted shares (in millions) 647.1 624.7 3.6%
Benefit expense as a percentage of
premiums 81.3% 80.4% 90 bp
Selling, general and administrative
expense as a percentage of total
operating revenue 15.7% 16.5% (80)bp
Income before income taxes as a
percentage of total revenues 8.6% 8.6% 0 bp
WellPoint, Inc.
Consolidated Balance Sheets
September 30, December 31,
($ In Millions) 2006 2005
(Unaudited)
Assets
Current assets:
Cash and cash equivalents $2,229.5 $2,740.2
Investments available-for-sale, at
fair value 2,274.8 2,182.8
Other invested assets, current 406.0 307.0
Accrued investment income 156.9 156.8
Premiums and self-funded receivables 2,598.0 2,216.4
Other receivables 1,129.9 831.4
Securities lending collateral 899.0 1,389.9
Deferred tax assets, net 784.5 689.0
Other current assets 1,158.4 1,022.7
Total current assets 11,637.0 11,536.2
Long-term investments 15,423.4 15,106.0
Property and equipment, net 993.4 1,078.6
Goodwill 13,455.9 13,469.1
Other intangible assets 9,469.0 9,686.4
Other noncurrent assets 505.5 410.9
Total assets $51,484.2 $51,287.2
Liabilities and shareholders' equity
Liabilities
Current liabilities:
Policy liabilities:
Medical claims payable $5,309.1 $4,853.4
Reserves for future policy benefits 81.9 82.1
Other policyholder liabilities 2,147.3 1,752.3
Total policy liabilities 7,538.3 6,687.8
Unearned income 1,057.7 1,057.1
Accounts payable and accrued expenses 3,244.2 2,860.4
Income taxes payable 539.9 833.4
Security trades pending payable 50.5 181.8
Securities lending payable 899.0 1,389.9
Current portion of long-term debt 221.5 481.2
Other current liabilities 1,399.5 1,286.8
Total current liabilities 14,950.6 14,778.4
Long-term debt, less current portion 7,122.2 6,324.7
Reserves for future policy benefits,
noncurrent 644.3 679.9
Deferred tax liability, net 3,323.2 3,267.1
Other noncurrent liabilities 1,300.5 1,244.0
Total liabilities 27,340.8 26,294.1
Shareholders' equity
Common stock 6.2 6.6
Additional paid-in capital 19,951.2 20,915.4
Retained earnings 4,167.1 4,173.5
Unearned stock compensation - (82.1)
Accumulated other comprehensive
income (loss) 18.9 (20.3)
Total shareholders' equity 24,143.4 24,993.1
Total liabilities and shareholders'
equity $51,484.2 $51,287.2
WellPoint, Inc.
Consolidated Statements of Cash Flows
(Unaudited)
Nine Months Ended September 30
($ In Millions) 2006 2005
Operating activities
Net income $2,293.8 $1,811.8
Adjustments to reconcile net income to net
cash provided by operating activities:
Net realized losses (gains)
on investments 11.4 (1.4)
Loss on disposal of assets 0.4 2.1
Deferred income taxes 27.8 (59.1)
Amortization, net of accretion 348.9 331.5
Depreciation 101.3 89.3
Share-based compensation 212.3 60.5
Excess tax benefits from share-based
compensation (113.4) -
Changes in operating assets and
liabilities, net of effect of business
combinations:
Receivables, net (676.2) (213.5)
Other invested assets, current (98.5) -
Other assets (229.4) (102.7)
Policy liabilities 806.8 (0.6)
Unearned income 0.6 122.7
Accounts payable and accrued expenses (45.2) 95.1
Other liabilities 122.7 (230.4)
Income taxes (150.0) 415.1
Net cash provided by operating activities 2,613.3 2,320.4
Investing activities
Purchases of fixed maturity securities (9,310.2) (12,404.3)
Proceeds from sales and maturities of
fixed maturity securities 9,121.1 11,337.5
Purchases of equity securities (2,136.1) (3,855.5)
Proceeds from sales of equity securities 1,841.5 3,757.7
Changes in securities lending collateral 490.9 (342.4)
Purchases of subsidiaries, net of
cash acquired (25.0) (330.2)
Payment for settlement of cash flow hedge (24.7) -
Purchases of property and equipment (130.5) (118.8)
Proceeds from sales of property and equipment 11.3 8.0
Net cash used in investing activities (161.7) (1,948.0)
Financing activities
Net proceeds from commercial paper borrowings 29.0 127.9
Proceeds from long-term borrowings 2,668.9 -
Repayment of long-term borrowings (2,159.5) (150.0)
Changes in securities lending payable (490.9) 342.4
Changes in bank overdrafts 414.5 (27.5)
Repurchase and retirement of common stock (4,000.0) (333.4)
Proceeds from exercise of employee stock
options and employee stock purchase plan 462.3 373.2
Proceeds from sale of put options - 1.1
Excess tax benefits from share-based
compensation 113.4 -
Net cash (used in) provided by
financing activities (2,962.3) 333.7
Change in cash and cash equivalents (510.7) 706.1
Cash and cash equivalents at
beginning of period 2,740.2 1,457.2
Cash and cash equivalents at end of period $2,229.5 $2,163.3
WellPoint, Inc.
Reconciliation of Medical Claims Payable
Nine Months Ended
September 30
($ In Millions) 2006 2005
(Unaudited)
Gross medical claims payable, beginning of period $4,853.4 $4,134.0
Ceded medical claims payable, beginning of period (27.7) (31.9)
Net medical claims payable, beginning of period 4,825.7 4,102.1
Business combinations and purchase adjustments (6.4) -
Net incurred medical claims:
Current year 31,845.2 24,707.8
Prior years (redundancies)(1) (576.5) (600.0)
Total net incurred medical claims 31,268.7 24,107.8
Net payments attributable to:
Current year medical claims 26,830.6 20,900.3
Prior years medical claims 3,989.3 3,233.0
Total net payments 30,819.9 24,133.3
Net medical claims payable, end of period 5,268.1 4,076.6
Ceded medical claims, end of period 41.0 31.1
Gross medical claims payable, end of period $5,309.1 $4,107.7
Current year medical claims paid as a percent of
current year net incurred medical claims 84.3% 84.6%
Prior year redundancies in the current period as a
percent of prior year net medical claims payables less
prior year redundancies in the current period 13.6% 17.1%
Prior year redundancies in the current period as a
percent of prior year net incurred medical claims -
as reported(3) 1.8% 3.9%
Prior year redundancies in the current period as a
percent of prior year net incurred medical claims -
adjusted for acquisitions(3) 1.5% 1.9%
Year Ended December 31
($ In Millions) 2005 2004 2003
Gross medical claims payable,
beginning of period $4,134.0 $1,836.0 $1,797.3
Ceded medical claims payable,
beginning of period (31.9) (8.7) (2.8)
Net medical claims payable,
beginning of period 4,102.1 1,827.3 1,794.5
Business combinations and
purchase adjustments 784.5 2,331.0 (20.6)
Net incurred medical claims:
Current year 32,865.6 15,344.9 12,316.7
Prior years (redundancies)(1) (644.9) (171.9) (225.9)
Total net incurred medical claims 32,220.7 15,173.0 12,090.8
Net payments attributable to:
Current year medical claims 28,997.1 12,453.2 10,546.5
Prior years medical claims 3,284.5 2,776.0 1,490.9
Total net payments 32,281.6 15,229.2 12,037.4
Net medical claims payable, end of period 4,825.7 4,102.1 1,827.3
Ceded medical claims, end of period 27.7 31.9 8.7
Gross medical claims payable,
end of period $4,853.4 $4,134.0 $1,836.0
Current year medical claims paid
as a percent of current year net
incurred medical claims 88.2% 81.2%(2) 85.6%
Prior year redundancies in the
current period as a percent of prior year
net medical claims payables less prior year
redundancies in the current period 18.7% 10.4% 14.4%
Prior year redundancies in the current
period as a percent of prior year net
incurred medical claims - as reported (3) 4.2% 1.4% 2.3%
Prior year redundancies in the current
period as a percent of prior year net
incurred medical claims - adjusted for
acquisitions (3) 2.1% 1.4% 2.0%
(1) Negative amounts reported for net incurred medical claims related to
prior years result from claims being settled for amounts less than originally
estimated.
(2) This ratio is impacted by having only one month of net incurred
medical claims and payments for the former WellPoint Health Networks Inc.
("WHN") in 2004. If WHN had not been included in 2004, current year medical
claims paid would have been $12,057.7 million, current year net incurred
medical claims would have been $13,835.1 million and the adjusted ratio would
have been 87.2%.
(3) For all periods presented, except for the year ended December 31,
2004, the reported ratio of prior year redundancies in the current period to
prior year net incurred medical claims is impacted by certain acquisitions
(the former WellChoice, Inc. in 2005, WHN in 2004 and the former Trigon
Healthcare, Inc. in 2002). The Company has provided ratios adjusted for these
acquisitions in order to demonstrate these impacts. Refer to the table
entitled, "Reconciliation of Medical Claims Payable - Adjusted Ratios" for
details regarding the respective calculation methodologies.
WellPoint, Inc.
Reconciliation of Medical Claims Payable - Adjusted Ratios
(Unaudited)
Note: Below are reconciliations for the adjusted ratios of prior year
redundancies in the current period to prior year net incurred medical claims
that are included in table entitled, "Reconciliation of Medical Claims
Payable."
Ratio for the Nine Months Ended September 30, 2006
This ratio is impacted by having no net incurred
medical claims for the former WellChoice, Inc.
("WC") in 2005.
Net incurred medical claims related to prior years
(redundancies) - nine months ended
September 30, 2006 (As Reported) $576.5
Net incurred medical claims - year ended
December 31, 2005 (As Reported) $32,865.6
Ratio (As Reported) 1.8%
Net incurred medical claims - year ended
December 31, 2005 (Comparable Basis)(1) $37,676.0
Ratio (As Adjusted) 1.5%
(1) Represents comparable benefit expense, assuming WC
had been owned for the entire year ended December 31, 2005.
Ratio for the Nine Months Ended September 30, 2005
This ratio is impacted by having only one month of
net incurred medical claims for the former
WellPoint Health Networks Inc. ("WHN") in 2004.
Net incurred medical claims related to prior years
(redundancies) - nine months ended
September 30, 2005 (As Reported) $600.0
Net incurred medical claims - year ended
December 31, 2004 (As Reported) $15,344.9
Ratio (As Reported) 3.9%
Net incurred medical claims - year ended
December 31, 2004 (Comparable Basis)(2) $30,819.1
Ratio (As Adjusted) 1.9%
(2) Represents comparable benefit expense, assuming WHN
had been owned for the entire year ended December 31, 2004.
Ratio for the Year Ended December 31, 2005
This ratio is impacted by having only one month of
net incurred medical claims for WHN in 2004.
Net incurred medical claims related to prior years
(redundancies) - year ended December 31, 2005
(As Reported) $644.9
Net incurred medical claims - year ended
December 31, 2004 (As Reported) $15,344.9
Ratio (As Reported) 4.2%
Net incurred medical claims - year ended
December 31, 2004 (Comparable Basis)(3) $30,819.1
Ratio (As Adjusted) 2.1%
(3) Represents comparable benefit expense, assuming WHN
had been owned for the entire year ended December 31, 2004.
Ratio for the Year Ended December 31, 2003
This ratio is impacted by having only five months
of net incurred medical claims for the former
Trigon Healthcare, Inc. ("TGH") in 2002.
Net incurred medical claims related to prior years
(redundancies) - year ended December 31, 2003
(As Reported) $225.9
Net incurred medical claims - year ended
December 31, 2002 (As Reported) $9,838.5
Ratio (As Reported) 2.3%
Net incurred medical claims - year ended
December 31, 2002 (Comparable Basis)(4) $11,057.8
Ratio (As Adjusted) 2.0%
(4) Represents comparable benefit expense, assuming TGH
had been owned for the entire year ended December 31, 2002.
WellPoint, Inc.
Selected Financial Data - Comparable Basis Analysis
(Unaudited)
($ In Millions) As Reported
Three Months Ended September 30
2006 2005 % Change
Revenues
Premiums $13,180.3 $10,182.1 29.4%
Administrative fees 867.8 688.9 26.0%
Other revenue 150.4 131.6 14.3%
Total operating revenue 14,198.5 11,002.6 29.0%
Expenses
Benefit expense 10,720.8 8,096.2 32.4%
Selling, general and administrative
expense
Selling expense 415.7 370.6 12.2%
General and administrative expense 1,783.0 1,477.2 20.7%
Total selling, general and
administrative expense 2,198.7 1,847.8 19.0%
Cost of drugs 71.4 73.8 (3.3%)
Benefit expense as a percentage of
premiums 81.3% 79.5% 180 bp
Selling, general and administrative
expense as a percentage of total
operating revenue 15.5% 16.8% (130)bp
($ In Millions) Comparable Basis(1)
Three Months Ended September 30
2005 $ Change % Change
Revenues
Premiums $11,673.7 $1,506.6 12.9%
Administrative fees 840.9 26.9 3.2%
Other revenue 131.7 18.7 14.2%
Total operating revenue 12,646.3 1,552.2 12.3%
Expenses
Benefit expense 9,392.7 1,328.1 14.1%
Selling, general and administrative
expense
Selling expense 390.1 25.6 6.6%
General and administrative expense 1,707.1 75.9 4.4%
Total selling, general and
administrative expense 2,097.2 101.5 4.8%
Cost of drugs 73.8 (2.4) (3.3%)
Benefit expense as a percentage of
premiums 80.5% 80 bp
Selling, general and administrative
expense as a percentage of total
operating revenue 16.6% (110)bp
($ In Millions) As Reported
Nine Months Ended September 30
2006 2005 % Change
Revenues
Premiums $38,678.0 $30,394.8 27.3%
Administrative fees 2,628.9 2,013.8 30.5%
Other revenue 448.6 385.8 16.3%
Total operating revenue 41,755.5 32,794.4 27.3%
Expenses
Benefit expense 31,443.9 24,424.9 28.7%
Selling, general and administrative
expense
Selling expense 1,230.3 1,097.7 12.1%
General and administrative expense 5,333.1 4,312.1 23.7%
Total selling, general and
administrative expense 6,563.4 5,409.8 21.3%
Cost of drugs 233.0 218.5 6.6%
Benefit expense as a percentage of
premiums 81.3% 80.4% 90 bp
Selling, general and administrative
expense as a percentage of total
operating revenue 15.7% 16.5% (80)bp
($ In Millions) Comparable Basis(1)
Nine Months Ended September 30
2005 $ Change % Change
Revenues
Premiums $34,738.5 $3,939.5 11.3%
Administrative fees 2,469.4 159.5 6.5%
Other revenue 385.7 62.9 16.3%
Total operating revenue 37,593.6 4,161.9 11.1%
Expenses
Benefit expense 28,169.8 3,274.1 11.6%
Selling, general and administrative
expense
Selling expense 1,153.4 76.9 6.7%
General and administrative expense 5,021.3 311.8 6.2%
Total selling, general and
administrative expense 6,174.7 388.7 6.3%
Cost of drugs 218.5 14.5 6.6%
Benefit expense as a percentage of
premiums 81.1% 20 bp
Selling, general and administrative
expense as a percentage of total
operating revenue 16.4% (70)bp
(1) The "Comparable Basis" information is a non-GAAP measure. Refer to the
tables entitled, "Reclassified Consolidated Statements of Income - Comparable
Basis Reconciliation."
WellPoint, Inc.
Reportable Segment Highlights - Comparable Basis Analysis
(Unaudited)
($ In Millions) As Reported
Three Months Ended September 30
2006 2005 % Change
Operating Revenue
Health Care Segment $13,644.9 $10,493.4 30.0%
Specialty Segment 902.7 768.8 17.4%
Other Segment (349.1) (259.6) (34.5%)
Total Operating Revenue 14,198.5 11,002.6 29.0%
Operating Gain (Loss)
Health Care Segment $1,093.9 $905.6 20.8%
Specialty Segment 128.7 100.2 28.4%
Other Segment (15.0) (21.0) 28.6%
Operating Margin(2)
Health Care Segment 8.0% 8.6% (60)bp
Specialty Segment 14.3% 13.0% 130 bp
($ In Millions) Comparable Basis(1)
Three Months Ended September 30
2005 $ Change % Change
Operating Revenue
Health Care Segment $12,096.6 $1,548.3 12.8%
Specialty Segment 776.9 125.8 16.2%
Other Segment (227.2) (121.9) (53.7%)
Total Operating Revenue 12,646.3 1,552.2 12.3%
Operating Gain (Loss)
Health Care Segment $1,006.1 $87.8 8.7%
Specialty Segment 100.2 28.5 28.4%
Other Segment (23.7) 8.7 36.7%
Operating Margin(2)
Health Care Segment 8.3% (30)bp
Specialty Segment 12.9% 140 bp
($ In Millions) As Reported
Nine Months Ended September 30
2006 2005 % Change
Operating Revenue
Health Care Segment $40,094.0 $31,251.4 28.3%
Specialty Segment 2,637.3 2,272.3 16.1%
Other Segment (975.8) (729.3) (33.8%)
Total Operating Revenue 41,755.5 32,794.4 27.3%
Operating Gain (Loss)
Health Care Segment $3,190.4 $2,539.5 25.6%
Specialty Segment 380.4 293.6 29.6%
Other Segment (55.6) (91.9) 39.5%
Operating Margin(2)
Health Care Segment 8.0% 8.1% (10)bp
Specialty Segment 14.4% 12.9% 150 bp
($ In Millions) Comparable Basis(1)
Nine Months Ended September 30
2005 $ Change % Change
Operating Revenue
Health Care Segment $35,926.9 $4,167.1 11.6%
Specialty Segment 2,296.4 340.9 14.8%
Other Segment (629.7) (346.1) (55.0%)
Total Operating Revenue 37,593.6 4,161.9 11.1%
Operating Gain (Loss)
Health Care Segment $2,834.7 $355.7 12.5%
Specialty Segment 294.1 86.3 29.3%
Other Segment (98.2) 42.6 43.4%
Operating Margin(2)
Health Care Segment 7.9% 10 bp
Specialty Segment 12.8% 160 bp
(1) The "Comparable Basis" information is a non-GAAP measure. Refer to
the tables entitled, "Reclassified Reportable Segment Highlights - Comparable
Basis Reconciliation."
(2) Operating margin is calculated as operating gain as a percentage of
operating revenue.
WellPoint, Inc.
Reclassified Consolidated Statements of Income - Comparable Basis
Reconciliation
(Unaudited)
Three Months Ended September 30, 2005
($ In Millions)
WLP (1) Reclassifications WLP (1)
As Reported (2) Reclassified
Revenues
Premiums $10,315.0 $(132.9) $10,182.1
Administrative fees 690.8 (1.9) 688.9
Other revenue (expense) 144.5 (12.9) 131.6
Total operating revenue 11,150.3 (147.7) 11,002.6
Net investment income 154.7 - 154.7
Net realized gains (losses) on
investments (0.4) - (0.4)
Total revenues 11,304.6 (147.7) 11,156.9
Expenses
Benefit expense 8,243.9 (147.7) 8,096.2
Selling, general and administrative
expense
Selling expense 370.6 - 370.6
General and administrative
expense 1,477.2 - 1,477.2
Total selling, general and
administrative expense 1,847.8 - 1,847.8
Cost of drugs 73.8 - 73.8
Interest expense 56.1 - 56.1
Amortization of other intangible
assets 59.6 - 59.6
Total expenses 10,281.2 (147.7) 10,133.5
Income before income taxes 1,023.4 - 1,023.4
Income taxes 382.7 - 382.7
Net income $640.7 $- $640.7
Benefit expense as a percentage of
premiums 79.9% 79.5%
Selling, general and administrative
expense as a percentage of total
operating revenue 16.6% 16.8%
Three Months Ended September 30, 2005
($ In Millions) WC(1)
As Reported Reclassifications(2)
Revenues
Premiums $1,505.7 $(14.1)
Administrative fees 140.7 11.3
Other revenue (expense) 0.1 -
Total operating revenue 1,646.5 (2.8)
Net investment income 22.5 -
Net realized gains (losses) on
investments 0.6 -
Total revenues 1,669.6 (2.8)
Expenses
Benefit expense 1,314.5 (18.0)
Selling, general and administrative
expense
Selling expense - 19.5
General and administrative expense 234.2 (4.3)
Total selling, general and
administrative expense 234.2 15.2
Cost of drugs - -
Interest expense - -
Amortization of other intangible
assets - -
Total expenses 1,548.7 (2.8)
Income before income taxes 120.9 -
Income taxes 45.2 -
Net income $75.7 $-
Benefit expense as a percentage of
premiums 87.3%
Selling, general and administrative
expense as a percentage of total
operating revenue 14.2%
Three Months Ended September 30, 2005
($ In Millions) WC(1) WellPoint, Inc.
Reclassified Comparable Basis(3)
Revenues
Premiums $1,491.6 $11,673.7
Administrative fees 152.0 840.9
Other revenue (expense) 0.1 131.7
Total operating revenue 1,643.7 12,646.3
Net investment income 22.5 177.2
Net realized gains (losses) on
investments 0.6 0.2
Total revenues 1,666.8 12,823.7
Expenses
Benefit expense 1,296.5 9,392.7
Selling, general and administrative
expense
Selling expense 19.5 390.1
General and administrative expense 229.9 1,707.1
Total selling, general and
administrative expense 249.4 2,097.2
Cost of drugs - 73.8
Interest expense - 56.1
Amortization of other intangible
assets - 59.6
Total expenses 1,545.9 11,679.4
Income before income taxes 120.9 1,144.3
Income taxes 45.2 427.9
Net income $75.7 $716.4
Benefit expense as a percentage of
premiums 86.9% 80.5%
Selling, general and administrative
expense as a percentage of total
operating revenue 15.2% 16.6%
(1) WLP = WellPoint, Inc.; WC = WellChoice, Inc.
(2) To reflect the reclassification of certain historical amounts to a
consistent presentation format adopted by the combined organization. In
connection with the acquisition of WellChoice, Inc., the Company adopted a
consistent practice for reporting minimum premium amendments to fully-insured
contracts throughout the combined enterprise.
(3) The "Comparable Basis" information was calculated by adding the
reclassified consolidated statements of income for WellPoint, Inc. and the
former WellChoice, Inc.
This "Comparable Basis" information contains no intercompany eliminations
or pro forma adjustments resulting from WellPoint, Inc.'s acquisition of
WellChoice, Inc.
"Comparable Basis" information is presented in order to provide investors
with a more meaningful comparison to the current period, due to the
acquisition of WellChoice, Inc.
"Comparable Basis" information is not calculated in accordance with GAAP
and is not intended to represent or be indicative of the results that
WellPoint, Inc. would have reported, had the acquisition been completed as of
January 1, 2005.
WellPoint, Inc.
Reclassified Consolidated Statements of Income - Comparable Basis
Reconciliation
(Unaudited)
Nine Months Ended September 30, 2005
($ In Millions) WLP(1) Reclassifications WLP(1)
As Reported (2) Reclassified
Revenues
Premiums $30,806.7 $(411.9) $30,394.8
Administrative fees 2,022.8 (9.0) 2,013.8
Other revenue (expense) 419.6 (33.8) 385.8
Total operating revenue 33,249.1 (454.7) 32,794.4
Net investment income 453.2 - 453.2
Net realized gains on investments 1.4 - 1.4
Total revenues 33,703.7 (454.7) 33,249.0
Expenses
Benefit expense 24,879.6 (454.7) 24,424.9
Selling, general and administrative
expense
Selling expense 1,097.7 - 1,097.7
General and administrative
expense 4,312.1 - 4,312.1
Total selling, general and
administrative expense 5,409.8 - 5,409.8
Cost of drugs 218.5 - 218.5
Interest expense 168.2 - 168.2
Amortization of other intangible
assets 178.7 - 178.7
Total expenses 30,854.8 (454.7) 30,400.1
Income before income taxes 2,848.9 - 2,848.9
Income taxes 1,037.1 - 1,037.1
Net income $1,811.8 $- $1,811.8
Benefit expense as a percentage of
premiums 80.8% 80.4%
Selling, general and administrative
expense as a percentage of total
operating revenue 16.3% 16.5%
Nine Months Ended September 30, 2005
($ In Millions) WC(1)
As Reported Reclassifications(2)
Revenues
Premiums $4,381.9 $(38.2)
Administrative fees 421.8 33.8
Other revenue (expense) (0.1) -
Total operating revenue 4,803.6 (4.4)
Net investment income 60.4 -
Net realized gains on investments 4.2 -
Total revenues 4,868.2 (4.4)
Expenses
Benefit expense 3,795.0 (50.1)
Selling, general and administrative
expense
Selling expense - 55.7
General and administrative expense 719.2 (10.0)
Total selling, general and
administrative expense 719.2 45.7
Cost of drugs - -
Interest expense - -
Amortization of other intangible
assets - -
Total expenses 4,514.2 (4.4)
Income before income taxes 354.0 -
Income taxes 132.8 -
Net income $221.2 $-
Benefit expense as a percentage of
premiums 86.6%
Selling, general and administrative
expense as a percentage of total
operating revenue 15.0%
Nine Months Ended September 30, 2005
($ In Millions) WC(1) WellPoint, Inc.
Reclassified Comparable Basis(3)
Revenues
Premiums $4,343.7 $34,738.5
Administrative fees 455.6 2,469.4
Other revenue (expense) (0.1) 385.7
Total operating revenue 4,799.2 37,593.6
Net investment income 60.4 513.6
Net realized gains on investments 4.2 5.6
Total revenues 4,863.8 38,112.8
Expenses
Benefit expense 3,744.9 28,169.8
Selling, general and administrative
expense
Selling expense 55.7 1,153.4
General and administrative expense 709.2 5,021.3
Total selling, general and
administrative expense 764.9 6,174.7
Cost of drugs - 218.5
Interest expense - 168.2
Amortization of other intangible assets - 178.7
Total expenses 4,509.8 34,909.9
Income before income taxes 354.0 3,202.9
Income taxes 132.8 1,169.9
Net income $221.2 $2,033.0
Benefit expense as a percentage of
premiums 86.2% 81.1%
Selling, general and administrative
expense as a percentage of total
operating revenue 15.9% 16.4%
(1) WLP = WellPoint, Inc.; WC = WellChoice, Inc.
(2) To reflect the reclassification of certain historical amounts to a
consistent presentation format adopted by the combined organization. In
connection with the acquisition of WellChoice, Inc., the Company adopted a
consistent practice for reporting minimum premium amendments to fully-insured
contracts throughout the combined enterprise.
(3) The "Comparable Basis" information was calculated by adding the
reclassified consolidated statements of income for WellPoint, Inc. and the
former WellChoice, Inc.
This "Comparable Basis" information contains no intercompany eliminations
or pro forma adjustments resulting from WellPoint, Inc.'s acquisition of
WellChoice, Inc.
"Comparable Basis" information is presented in order to provide investors
with a more meaningful comparison to the current period, due to the
acquisition of WellChoice, Inc.
"Comparable Basis" information is not calculated in accordance with GAAP
and is not intended to represent or be indicative of the results that
WellPoint, Inc. would have reported, had the acquisition been completed as of
January 1, 2005.
WellPoint, Inc.
Reclassified Reportable Segment Highlights - Comparable Basis
Reconciliation
(Unaudited)
Three Months Ended September 30, 2005
($ In Millions) WLP(1) Reclassifications WLP(1)
As Reported (2) Reclassified
Operating Revenue(4)
Health Care $10,674.5 $(181.1) $10,493.4
Specialty 723.1 45.7 768.8
Other (247.3) (12.3) (259.6)
Commercial Managed Care - - -
Other Insurance Products and
Services - - -
Total operating revenue 11,150.3 (147.7) 11,002.6
Operating Gain (Loss)(4)
Health Care 916.6 (11.0) 905.6
Specialty 89.2 11.0 100.2
Other (21.0) - (21.0)
Commercial Managed Care - - -
Other Insurance Products and
Services - - -
Three Months Ended September 30, 2005
($ In Millions) WC (1)
As Reported Reclassifications(2)
Operating Revenue(4)
Health Care $- $1,603.2
Specialty - 8.1
Other - 32.4
Commercial Managed Care 1,429.3 (1,429.3)
Other Insurance Products and Services 217.2 (217.2)
Total operating revenue 1,646.5 (2.8)
Operating Gain (Loss)(4)
Health Care - 100.5
Specialty - -
Other - (2.7)
Commercial Managed Care 90.4 (90.4)
Other Insurance Products and Services 7.4 (7.4)
Three Months Ended September 30, 2005
($ In Millions) WC(1) WellPoint, Inc.
Reclassified Comparable Basis(3)
Operating Revenue(4)
Health Care $1,603.2 $12,096.6
Specialty 8.1 776.9
Other 32.4 (227.2)
Commercial Managed Care - -
Other Insurance Products and Services - -
Total operating revenue 1,643.7 12,646.3
Operating Gain (Loss)(4)
Health Care 100.5 1,006.1
Specialty - 100.2
Other (2.7) (23.7)
Commercial Managed Care - -
Other Insurance Products and Services - -
Nine Months Ended September 30, 2005
($ In Millions) WLP(1) Reclassifications WLP(1)
As Reported (2) Reclassified
Operating Revenue(4)
Health Care $31,814.7 $(563.3) $31,251.4
Specialty 2,114.4 157.9 2,272.3
Other (680.0) (49.3) (729.3)
Commercial Managed Care - - -
Other Insurance Products and
Services - - -
Total operating revenue 33,249.1 (454.7) 32,794.4
Operating Gain (Loss)(4)
Health Care 2,562.8 (23.3) 2,539.5
Specialty 273.0 20.6 293.6
Other (94.6) 2.7 (91.9)
Commercial Managed Care - - -
Other Insurance Products and Services - - -
Nine Months Ended September 30, 2005
($ In Millions) WC (1)
As Reported Reclassifications(2)
Operating Revenue(4)
Health Care $- $4,675.5
Specialty - 24.1
Other - 99.6
Commercial Managed Care 4,131.8 (4,131.8)
Other Insurance Products and Services 671.8 (671.8)
Total operating revenue 4,803.6 (4.4)
Operating Gain (Loss)(4)
Health Care - 295.2
Specialty - 0.5
Other - (6.3)
Commercial Managed Care 236.4 (236.4)
Other Insurance Products and Services 53.0 (53.0)
Nine Months Ended September 30, 2005
($ In Millions) WC(1) WellPoint, Inc.
Reclassified Comparable Basis(3)
Operating Revenue(4)
Health Care $4,675.5 $35,926.9
Specialty 24.1 2,296.4
Other 99.6 (629.7)
Commercial Managed Care - -
Other Insurance Products and Services - -
Total operating revenue 4,799.2 37,593.6
Operating Gain (Loss) (4)
Health Care 295.2 2,834.7
Specialty 0.5 294.1
Other (6.3) (98.2)
Commercial Managed Care - -
Other Insurance Products and Services - -
(1) WLP = WellPoint, Inc.; WC = WellChoice, Inc.
(2) To reflect the reclassification of certain historical amounts to a
consistent presentation format adopted by the combined organization. In
connection with the acquisition of WellChoice, Inc., the Company adopted a
consistent practice for reporting minimum premium amendments to fully-insured
contracts throughout the combined enterprise.
(3) The "Comparable Basis" information was calculated by adding the
reclassified consolidated statements of income for WellPoint, Inc. and the
former WellChoice, Inc.
This "Comparable Basis" information contains no intercompany eliminations
or pro forma adjustments resulting from WellPoint, Inc.'s acquisition of
WellChoice, Inc.
"Comparable Basis" information is presented in order to provide investors
with a more meaningful comparison to the current period, due to the
acquisition of WellChoice, Inc.
"Comparable Basis" information is not calculated in accordance with GAAP
and is not intended to represent or be indicative of the results that
WellPoint, Inc. would have reported, had the acquisition been completed as of
January 1, 2005.
(4) Operating revenue and operating gain are the key measures used by
management to evaluate performance in each segment. Operating gain is defined
as operating revenue less benefit expense, selling expense, general and
administrative expense, and cost of drugs. Operating gain is used to analyze
profit or loss on a segment basis.
Consolidated operating gain is a non-GAAP measure.
WellPoint, Inc.
Operating Cash Flow as a Multiple of Net Income
(Unaudited)
($ In Millions) Three Months Ended September 30, 2006(1)
Average CMS
As Reported Monthly Payments Adjusted
Operating cash flow $614.7 $448.4 $1,063.1
Net Income $810.8 - $810.8
Operating cash flow as a
multiple of net income 0.8 - 1.3
(1) Operating cash flow for the three months ended September 30, 2006,
included only two CMS payments of approximately $448.4 million each. If the
Company had received a third CMS payment during the quarter to correspond to
three months of disbursements, operating cash flow would have been 1.3 times
net income. Due to the magnitude of these payments, the Company has presented
the "Operating Cash Flow as a Multiple of Net Income" metric on an adjusted
basis (which includes these payments in the third quarter 2006 operating cash
flow) in order to facilitate period-to-period analysis.
SAFE HARBOR STATEMENT UNDER THE PRIVATE SECURITIES
LITIGATION REFORM ACT OF 1995
This press release contains certain forward-looking information about
WellPoint, Inc. ("WellPoint") that is intended to be covered by the safe
harbor for "forward-looking statements" provided by the Private Securities
Litigation Reform Act of 1995. Forward-looking statements are statements that
are not historical facts. Words such as "expect(s)", "feel(s)", "believe(s)",
"will", "may", "anticipate(s)" and similar expressions are intended to
identify forward-looking statements. These statements include, but are not
limited to, financial projections and estimates and their underlying
assumptions; statements regarding plans, objectives and expectations with
respect to future operations, products and services; and statements regarding
future performance. Such statements are subject to certain risks and
uncertainties, many of which are difficult to predict and generally beyond the
control of WellPoint, that could cause actual results to differ materially
from those expressed in, or implied or projected by, the forward-looking
information and statements. These risks and uncertainties include: those
discussed and identified in public filings with the U.S. Securities and
Exchange Commission ("SEC") made by WellPoint and WellChoice, Inc.
("WellChoice"); trends in health care costs and utilization rates; our ability
to secure sufficient premium rate increases; competitor pricing below market
trends of increasing costs; increased government regulation of health benefits
and managed care; significant acquisitions or divestitures by major
competitors; introduction and utilization of new prescription drugs and
technology; a downgrade in our financial strength ratings; litigation and
investigations targeted at health benefits companies and our ability to
resolve litigation and investigations within estimates; our ability to
contract with providers consistent with past practice; other potential uses of
cash in the future that present attractive alternatives to share repurchases;
our ability to achieve expected synergies and operating efficiencies in the
WellPoint Health Networks Inc. merger and WellChoice acquisition within the
expected time-frames or at all and to successfully integrate our operations;
such integration may be more difficult, time-consuming or costly than
expected; revenues following the transactions may be lower than expected;
operating costs, customer loss and business disruption, including, without
limitation, difficulties in maintaining relationships with employees,
customers, clients or suppliers, may be greater than expected following the
transactions; our ability to meet expectations regarding repurchases of shares
of our common stock; our ability to meet expectations regarding the accounting
and tax treatments of the transactions and the value of transaction
consideration; future bio-terrorist activity or other potential public health
epidemics; and general economic downturns. Readers are cautioned not to place
undue reliance on these forward-looking statements that speak only as of the
date hereof. WellPoint does not undertake any obligation to republish revised
forward-looking statements to reflect events or circumstances after the date
hereof or to reflect the occurrence of unanticipated events. Readers are also
urged to carefully review and consider the various disclosures in WellPoint's
and WellChoice's various SEC reports, including but not limited to WellPoint's
Annual Report on Form 10-K for the year ended December 31, 2005, and its
Quarterly Reports on Form 10-Q for the reporting periods of 2006.
SOURCE WellPoint, Inc.
CONTACT: Investor Relations: Wayne DeVeydt, +1-317-488-6390, Media:
Karen Brown, +1-317-488-6438, both of WellPoint, Inc.